Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Lexicon Pharmaceuticals (LXRX) Shares Repurchased (2023 - 2024)

Lexicon Pharmaceuticals (LXRX) has disclosed Shares Repurchased for 4 consecutive years, with $1.7 million as the latest value for Q1 2024.

  • On a quarterly basis, Shares Repurchased rose 109.95% to $1.7 million in Q1 2024 year-over-year; TTM through Dec 2024 was $1.7 million, a 109.95% increase, with the full-year FY2024 number at $1.7 million, up 109.95% from a year prior.
  • Shares Repurchased was $1.7 million for Q1 2024 at Lexicon Pharmaceuticals, up from $824000.0 in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $1.7 million in Q1 2024 to a low of $824000.0 in Q1 2023.